ReviewBiomedicines2026
Pulmonary Complications in Cirrhosis: Current Concepts and Clinical Perspectives.
Review in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The liver and lungs maintain an essential anatomical and physiological network crucial for systemic homeostasis. In the presence of cirrhosis, particularly when accompanied by portal hypertension, this intricate communication is disrupted. The resulting alterations can lead to a range of pulmonary complications through intertwined vascular, immunologic, and mechanical mechanisms that underscore the close relationship between these two organs. This review provides an overview of the liver-lung axis and summarizes current concepts of the pathophysiological processes by which advanced liver disease contributes to major respiratory complications. It also highlights diagnostic principles and clinical manifestations, with emphasis on hepatopulmonary syndrome, portopulmonary hypertension, and hepatic hydrothorax. Although these conditions differ substantially in their underlying pathogenesis, they share common clinical consequences, including impaired arterial oxygenation, reduced functional capacity, and an increased risk of mortality prior to liver transplantation. In addition, the review explores the ongoing debate regarding the potential association between chronic hepatitis C virus infection and pulmonary fibrosis. Overall, early recognition of these pulmonary complications is crucial, as they have important implications for symptom burden, therapeutic decision-making, liver transplant eligibility, and overall clinical outcomes in patients with chronic liver disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.